ESTONIA: Estonia Unveils Plan to Cut EU's Highest Per Capita HIV Rate

Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.

ESTONIA: Estonia Unveils Plan to Cut EU's Highest Per Capita HIV Rate

Agence France Presse (12.01.05) - Thursday, December 08, 2005

On World AIDS Day, Estonia revealed its plan to slash new HIV infections from the current level of 55 per 100,000 people, the highest rate in Europe, to 20 per 100,000 by 2015. According to experts, the country of 1.4 million is in the "worst position in the world, outside Africa" in terms of HIV infections. "The infection of people with HIV is out of control in Estonia," said Maarike Harro, director of the National Institute for Health Development (NIHD).

In the first 10 months of 2005, Estonia registered 569 new HIV cases, 60 percent of whom were under age 25, bringing the total number of HIV-positive Estonians to more than 5,000. During that same period, 19 people were diagnosed with AIDS, for a total of 89.

At the turn of the century, Estonia was almost HIV-free. But in the autumn of 2000, the Baltic state saw a sudden upsurge in cases among drug addicts in Narva, a city to the northeast that borders Russia and is home to a large ethnic Russian population. HIV spread quickly via IV drug users sharing needles, and many then passed it on through unprotected sex with their partners.

"The virus keeps spreading among intravenous drug addicts but more new HIV cases are registered also among their sexual partners," said Kristi Ruutel, an HIV/AIDS expert at NIHD. "These two are the main risk groups we are trying to focus on at present."

To control HIV's spread, Estonia will sharply increase its funding for the disease from $4.2 million this year to $30 million by 2009, said Social Affairs Minister Jaak Aab.
051208
AD052475

Copyright © 2005 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.